2 November 2023
Herbert Smith Freehills advises Zydus Lifesciences Limited on acquisition of the UK based LiqMeds Group
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Alan Montgomery Lead | Herbert Smith Freehills Kramer | Partner | Corporate | Not stated |
| Martyn Jones | Herbert Smith Freehills Kramer | Counsel | Corporate | Not stated |
| Meera Thakrar | Herbert Smith Freehills Kramer | Associate | Corporate | Not stated |
| Adya Garg | Herbert Smith Freehills Kramer | Associate | Corporate | Not stated |
| Savannah Van Dongen | Herbert Smith Freehills Kramer | Associate | Corporate | Not stated |
| Kate Peck | Herbert Smith Freehills Kramer | Associate | IP | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- GBP 68m (£68m)
- What the figure measures
- Total transaction value
- Client
- Zydus Pharmaceuticals UK LimitedBuy-side
- Counterparties
- LiqMeds group of companies (Sell-side)